Therapeutic Asset Ratings

862 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
PREDNISONE TABLETS Adenocarcinoma of the Prostate	Mayo Clinic	P3	BB (70)
Zofran Chronic Lymphocytic Leucemia	Mayo Clinic	P3	BB (70)
PEGFILGRASTIM Ann Arbor Stage II Follicular Lymphoma	Mayo Clinic	P2	BB (70)
PEGFILGRASTIM Recurrent Grade 3 Follicular Lymphoma	Mayo Clinic	P2	BB (70)
Cariprazine Major Depressive Disorder	Mayo Clinic	P4	BB (69)
IOFLUPANE Dementia	Mayo Clinic	P4	BB (69)
Naltrexone Schizoaffective Disorder	Mayo Clinic	P4	BB (69)
Triamcinalone Osteoarthritis of Knee	Mayo Clinic	P4	BB (69)
Vortioxetine Bipolar Depression	Mayo Clinic	P4	BB (69)
Wellbutrin Schizoaffective Disorder	Mayo Clinic	P4	BB (69)
Acetylsalicylic Acid Breast Cancer Survivors	Mayo Clinic	P3	BB (69)
LEUPROLIDE Prostate Adenocarcinoma	Mayo Clinic	P3	BB (69)
Zoladex Recurrent Prostate Carcinoma	Mayo Clinic	P3	BB (69)
FILGRASTIM Recurrent Chronic Lymphocytic Leukemia	Mayo Clinic	P2	BB (69)
Dapagliflozin Lewy Body Dementia	Mayo Clinic	P4	BB (68)
PREDNISONE TABLETS Prostate Cancer	Mayo Clinic	P4	BB (68)
Sitagliptin Lewy Body Dementia	Mayo Clinic	P4	BB (68)
Calcium folinate pentahydrate B-cell Adult Acute Lymphoblastic Leukemia	Mayo Clinic	P3	BB (68)
FILGRASTIM Metastatic Cancer	Mayo Clinic	P3	BB (68)
FLUTICASONE Melanoma (Skin)	Mayo Clinic	P3	BB (68)
Sargramostim Melanoma (Skin)	Mayo Clinic	P3	BB (68)
Sargramostim Stage IV Breast Cancer	Mayo Clinic	P3	BB (68)
Cyclophosphamide Recurrent Fallopian Tube Carcinoma	Mayo Clinic	P2	BB (68)
FLUTICASONE Stage IV Breast Cancer	Mayo Clinic	P2	BB (68)
Abiraterone Acetate Prostate Cancer	Mayo Clinic	P4	BB (67)

Showing 26 to 50 of 862 assets